DAX22.513 -0,4%ESt505.493 -0,1%Top 10 Crypto14,91 +4,4%Dow44.546 -0,4%Nas20.027 +0,4%Bitcoin93.110 +0,3%Euro1,0493 +0,3%Öl74,64 -0,9%Gold2.884 ±0,0%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 NVIDIA 918422 BASF BASF11 Tesla A1CX3T Commerzbank CBK100 Volkswagen (VW) vz. 766403 Mercedes-Benz Group (ex Daimler) 710000 Siemens Energy ENER6Y BYD A0M4W9 Siemens 723610 Allianz 840400 Deutsche Telekom 555750 Palantir A2QA4J Bayer BAY001 RENK RENK73
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
US-Börsen schließen mit uneinheitlicher Tendenz -- DAX geht etwas leichter ins Wochenende -- NVIDIAs Depot in Q4 -- Moderna mit massiven Verlusten -- Coinbase, Arm, Palo Alto, Rheinmetall im Fokus
Top News
DAX in KW 7: Die größten Gewinner und Verlierer im Überblick DAX in KW 7: Die größten Gewinner und Verlierer im Überblick
Hot Stocks heute: US-Chipwerte gefragt - Aktien in der Besprechung Intel, Wolfspeed und Applied Materials Hot Stocks heute: US-Chipwerte gefragt - Aktien in der Besprechung Intel, Wolfspeed und Applied Materials
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

TruDiagnostic Announces $400K Epigenetics Discovery Grant to Advance Scientific Innovation

14.02.25 14:18 Uhr

LEXINGTON, Ky., Feb. 14, 2025 /PRNewswire/ -- TruDiagnostic, a leader in epigenetic testing and research, has announced the launch of the TruDiscovery Grant which offers $400,000 in funding for researchers and organizations pioneering advancements in DNA methylation, longevity science, and diagnostic innovation.

TruDiagnostic Logo (PRNewsfoto/TruDiagnostic)

As a leading CLIA-certified epigenetics lab, TruDiagnostic has built one of the world's largest private methylation databases, testing over 100,000 patients since 2020. This grant aims to bridge the gap between research and real-world applications, empowering scientists, biotech firms, and academic institutions working on innovative DNAm biomarkers and aging algorithms.

At a time when government funding for critical research remains on hold, TruDiagnostic is stepping up. Their commitment to advancing Epigenetic Research ensures that innovation and progress continue without interruption. By funding this grant, they are empowering researchers to pursue groundbreaking work that might otherwise be stalled due to funding delay.

"We believe epigenetics is the future of medicine," said Ryan Smith, Founder at TruDiagnostic. "By investing in the next generation of researchers, we can unlock new diagnostic tools, predictive models, and treatments that transform patient care."

Key Details:

  • Funding: $400,000 for selected projects
  • Eligibility: Open to researchers, biotech startups, and academic institutions
  • Bonus Incentive: $10,000 referral bonus for connecting the grant winner
  • Introduction Webinar: March 12th, 2025. Register Here: https://us06web.zoom.us/webinar/register/WN_T4gF6gweSUS2E4dQb9J8HA
  • Deadline to Apply: April 5th, 2025
  • Award Announcement: May 4th, 2025

To apply or learn more, visit trudiagnostic.com/trudiscovery-grant.

For media inquiries, please contact: press@trudiagnostic.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/trudiagnostic-announces-400k-epigenetics-discovery-grant-to-advance-scientific-innovation-302377089.html

SOURCE TruDiagnostic